Alterity Therapeutics Ltd ATH
News
Alterity Therapeutics Releases Appendix 4C – Q1 FY27 Quarterly Cash Flow Report & Corporate Update
Alterity Therapeutics to Present at the Canaccord Genuity Drug and Device Conference
Alterity Therapeutics Presents New Analyses of ATH434 Phase 2 Data in Multiple System Atrophy at the 2026 International Congress of Parkinson’s Disease and Movement Disorders
Alterity Therapeutics to Participate in a Fireside Chat at the Cantor Global Healthcare Conference 2026
